Webinar replay
Biopharma Dealmaking in 2021: Trends and Transformation
After a turbulent year of remote dealmaking under COVID-19 restrictions, the biopharma sector has kicked off 2021 with renewed vigor. Billion dollar deals abound, merger and acquisition activities are accelerating, and deals are being made earlier and faster than ever.
In this exclusive webinar, Chris Dokomajilar, founder and CEO of DealForma, and Gilles Toulemonde, CEO of Inova, will present the trends they are tracking and speak to the ongoing digital transformation of biopharma dealmaking. They'll discuss what deals have been done so far in 2021, identify some of the difficulties that pharma companies are experiencing in attracting biotechs, and explain what to watch in deal making and partnering best practices for the second half of 2021.
Please complete the form below
All fields marked with a * are required.
By submitting this form, you agree to the storing and processing of your
personal data by Inova as detailed in the Privacy Statement.
personal data by Inova as detailed in the Privacy Statement.
About Inova
Inova accelerates partnering for the future of medicine.
Our cloud-based solutions help life science companies manage
their biopharma opportunities more efficiently. They find all their
partnering information in one place, track their deals and alliances
easily and report on their pipeline and activities in seconds.
We have also developed strategic partnerships that make data from
the 20 biggest biopharma events automatically available in Inova,
providing our users with always up-to-date company and contact
information. Over 150 life science companies, including 50% of the
top 50 pharmaceutical companies and many midsize pharma and
innovative biotechs already use Inova.